130 related articles for article (PubMed ID: 35724824)
1. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU.
Akkın S; Varan G; Aksüt D; Malanga M; Ercan A; Şen M; Bilensoy E
Int J Pharm; 2022 Jul; 623():121940. PubMed ID: 35724824
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer.
Akkın S; Varan G; Işık A; Gökşen S; Karakoç E; Malanga M; Esendağlı G; Korkusuz P; Bilensoy E
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839637
[TBL] [Abstract][Full Text] [Related]
3. Pressure responsive nanogel base on Alginate-Cyclodextrin with enhanced apoptosis mechanism for colon cancer delivery.
Hosseinifar T; Sheybani S; Abdouss M; Hassani Najafabadi SA; Shafiee Ardestani M
J Biomed Mater Res A; 2018 Feb; 106(2):349-359. PubMed ID: 28940736
[TBL] [Abstract][Full Text] [Related]
4. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery.
Varan G; Benito JM; Mellet CO; Bilensoy E
Beilstein J Nanotechnol; 2017; 8():1457-1468. PubMed ID: 28900599
[No Abstract] [Full Text] [Related]
5. Cationic cyclodextrin/alginate chitosan nanoflowers as 5-fluorouracil drug delivery system.
Lakkakula JR; Matshaya T; Krause RW
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):169-177. PubMed ID: 27770878
[TBL] [Abstract][Full Text] [Related]
6. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
Prabha G; Raj V
Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
Anitha A; Deepa N; Chennazhi KP; Lakshmanan VK; Jayakumar R
Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.
Zhao L; Wang WJ; Zhang JN; Zhang XY
Asian Pac J Cancer Prev; 2014; 15(9):4039-44. PubMed ID: 24935593
[TBL] [Abstract][Full Text] [Related]
9. Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.
Pangeni R; Choi SW; Jeon OC; Byun Y; Park JW
Int J Nanomedicine; 2016; 11():6379-6399. PubMed ID: 27942212
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
11. Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin.
Ünal H; Öztürk N; Bilensoy E
Beilstein J Org Chem; 2015; 11():204-12. PubMed ID: 25815071
[TBL] [Abstract][Full Text] [Related]
12. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
13. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer.
Tang Q; Wang Y; Huang R; You Q; Wang G; Chen Y; Jiang Z; Liu Z; Yu L; Muhammad S; Wang X
PLoS One; 2014; 9(6):e98455. PubMed ID: 24896096
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic Effect of 5-Fluorouracil-loaded Polymer-coated Magnetite Nanographene Oxide Combined with Radiofrequency.
Asadi L; Shirvalilou S; Khoee S; Khoei S
Anticancer Agents Med Chem; 2018; 18(8):1148-1155. PubMed ID: 29623854
[TBL] [Abstract][Full Text] [Related]
15. Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells.
Abd-Rabou AA; Shalby AB; Ahmed HH
Biol Trace Elem Res; 2019 Jan; 187(1):80-91. PubMed ID: 29748931
[TBL] [Abstract][Full Text] [Related]
16. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
Li S; Wang A; Jiang W; Guan Z
BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
[TBL] [Abstract][Full Text] [Related]
19. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
20. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
